Alnylam Pharma(MX:ALNY)
MX$2,950.00+40.00 (+1.37%)
MX:ALNY
Alnylam Pharma earnings date
MX$2,950.00
At close:+40.00 (+1.37%)
Alnylam Pharma (ALNY) Q3 2023 Earnings Report
0 Followers
MX:ALNY Q3 2023 EPS Results
- Actual EPS
- MXN 21.39
- Consensus EPS
- -MXN 26.90
- Beat/Miss
- Beat by +MXN 48.29
- One Year Ago EPS
- -MXN 61.75
MX:ALNY Q3 2023 Revenue Results
- Actual Revenue
- MXN 13.96B
- Expected Revenue
- MXN 7.38B
- Beat/Miss
- Beat by +MXN 6.58B
- YoY Revenue Growth
- +183.96%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/02/2023
- Time
- Before Open
- Conference Call
- Thursday, November 2, 2023
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
MX:ALNY Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 32.01- | 15.25 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 30.88292.39 | 34.22 | 754.35% (+258.17) | |
| Jul 30, 2026 | 2026 (Q2) | 30.3222.51 | -9.49 | 337.25% (+31.99) | |
| Apr 30, 2026 | 2026 (Q1) | 16.2228.09 | -8.18 | 443.18% (+36.27) | |
| Feb 12, 2026 | 2025 (Q4) | 21.3915.25 | -12.09 | 226.15% (+27.34) | |
| Oct 30, 2025 | 2025 (Q3) | 10.4334.22 | -16.18 | 311.49% (+50.41) | |
| Jul 31, 2025 | 2025 (Q2) | -10.12-9.49 | -2.42 | -292.31% (-7.07) | |
| May 01, 2025 | 2025 (Q1) | -16.55-8.18 | -9.67 | 15.38% (+1.49) | |
| Feb 13, 2025 | 2024 (Q4) | -11.01-12.09 | -20.46 | 40.91% (+8.37) | |
| Oct 31, 2024 | 2024 (Q3) | -17.06-16.18 | 21.39 | -175.65% (-37.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
